Sa1153 Impact of Concomitant Immunosuppressant Use on Adalimumab Efficacy in Children With Moderately to Severely Active Crohn's Disease: Results From IMAgINE 1

MLA

Roopal Thakkar, et al. “Sa1153 Impact of Concomitant Immunosuppressant Use on Adalimumab Efficacy in Children With Moderately to Severely Active Crohn’s Disease: Results From IMAgINE 1.” Gastroenterology, vol. 146, May 2014, p. S-214. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........e900d6f30e17aad05d8d9be1c0f39b68&authtype=sso&custid=ns315887.

APA

Roopal Thakkar, Jaroslaw Kierkus, Jeffrey S. Hyams, Andreas Lazar, Frank M. Ruemmele, Richard B. Colletti, Samantha Eichner, Joel R. Rosh, & Yao Li. (2014). Sa1153 Impact of Concomitant Immunosuppressant Use on Adalimumab Efficacy in Children With Moderately to Severely Active Crohn’s Disease: Results From IMAgINE 1. Gastroenterology, 146, S-214.

Chicago

Roopal Thakkar, Jaroslaw Kierkus, Jeffrey S. Hyams, Andreas Lazar, Frank M. Ruemmele, Richard B. Colletti, Samantha Eichner, Joel R. Rosh, and Yao Li. 2014. “Sa1153 Impact of Concomitant Immunosuppressant Use on Adalimumab Efficacy in Children With Moderately to Severely Active Crohn’s Disease: Results From IMAgINE 1.” Gastroenterology 146 (May): S-214. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........e900d6f30e17aad05d8d9be1c0f39b68&authtype=sso&custid=ns315887.